< BACK TO SCIENTIFIC PROGRAM

Monday, June 15, 2:00 – 3:30 pm
Auditorium Lulli

Talks:

1. What does the San Diego Consensus change in clinic?  
2. Is GMA biomarker subtyping the key to understanding and treating GERD/LPR?  
3. Alginate, H2RA, PPI, neuromodulation, or lifestyle first—what’s your first script? 
4. What is the current understanding of the role of reflux in promoting laryngopharngeal cancer? 
5. Are PCABs effective for LPRD?  
6. What is the status of pepsin inhibitors for LPR? 
7. Which surgical or endoscopic options work for extra-esophageal disease?
8. Pediatrics: are kids just little adults when it comes to LPRD?

Motion: "This house supports the San Diego Consensus Statement as the governing guideline for LPRD."

• FOR: (defending the Consensus statements & pathways). 
• AGAINST: (challenging external validity, symptom-first pathways, and laryngology-specific nuances). 

Format: 5-minute opening per side → 5-minute discussion → 5-minute audience Q&A → live poll - vote on the debate motion.

Case-Based Panel + Audience Interaction:

Rapid Cases (5 minutes each x3)

1. Professional singer with chronic throat clearing and normal EGD: “Treat or test first?”
2. Chronic cough with normal acid exposure but high non-acid events: “Does therapy change?”
3. Mucosal protection: formulations and their place in the management of GERD and LPR
4. Refractory LPS after maximal PPI & alginate: “Is it time for surgery or is it not reflux?”

3 take-home messages aligned to consensus language